drugset / Trial / NCT05348408

Efficacy of Peri-neural Platelet Rich Plasma Injection in Treatment of Chemotherapy Induced Peripheral Neuropathy

NCT05348408

Phase 2 Completed 62 enrolled South Egypt Cancer Institute
RandomizedParallel-groupSingle-blindTreatment

Summary

This study aims to show the efficacy and safety of ultra-sound guided peri-neural platelet rich injection in treatment of chemotherapy induced peripheral neuropathy.

Timeline

Start
2022-04-01
Primary completion
2024-12-30
Completion
2024-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Platelet Rich Plasma Other / unclassified 1.5 ml Other
Comparator Platelet Rich Plasma Other / unclassified 3 ml Other